A. COVID-19 vaccines induce higher levels and a broader range of neutralizing antibodies to the receptor binding domain (RBD) of the spike protein than does natural infection. Vaccine-induced antibodies are less likely to be affected by changes in the RBD seen in the current SARS-CoV-2 variants, and are therefore more likely to be more effective Read more…